|
EP3116474A1
|
|
Low-dose estradiol cream
|
|
WO2014152269A1
|
|
Pharmaceutical soft gelatin capsule dosage form with modified guar gum
|
|
CN105392476A
|
|
Pharmaceutical soft gelatin capsule dosage form
|
|
US2014271859A1
|
|
Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability
|
|
US2013217701A1
|
|
Compositions of azimilide dihydrochloride
|
|
US2013183353A1
|
|
Low dosage forms of risedronate or its salts
|
|
US2013177645A1
|
|
Low dosage forms of risedronate or its salts
|
|
US2014141075A1
|
|
5-aminosalicylic acid capsule formulation
|
|
JP2012107058A
|
|
Pharmaceutical dosage form with multiple coatings
|
|
CN102630227A
|
|
Bisphosphonate compounds for treating bone metabolism disorders
|
|
WO2010014765A1
|
|
Low dosage forms of risedronate or its salts
|
|
SG174785A1
|
|
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailabilty
|
|
NZ570494A
|
|
Malate salts, and polymorphs of (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
|
|
AU2006348138A1
|
|
Methods of treatment for ulcerative colitis using aminosalicylate
|
|
NZ561708A
|
|
Dosage forms of risedronate
|
|
US2006241091A1
|
|
Extended estrogen dosing contraceptive regimen
|
|
KR20120104446A
|
|
Enteric solid oral dosage form of bisphosphonate containing a chelating agent
|
|
AU2004261143A1
|
|
A doxycycline metal complex in a solid dosage form
|
